106 related articles for article (PubMed ID: 10072815)
1. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
Ran R; Cao XA; Tian Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
[TBL] [Abstract][Full Text] [Related]
2. [Homozygous deletion of CDKN2/p16 gene in lung cancers].
Su C; Ye Y; Cao X; Shan X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):315-7. PubMed ID: 10514540
[TBL] [Abstract][Full Text] [Related]
3. [p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers].
Wang G; Du C; Lin Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):5-8. PubMed ID: 9456359
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between tumor suppressor gene p16 and Rb and early diagnosis of lung cancers].
Ye Y; Su C; Wang D; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):537-41, 30. PubMed ID: 11832104
[TBL] [Abstract][Full Text] [Related]
5. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
6. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.
Panani AD; Maliaga K; Babanaraki A; Bellenis I
Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395
[TBL] [Abstract][Full Text] [Related]
7. Relations of tumor suppressor gene p16 and RB to early diagnosis of lung cancer.
Ye Y; Su C; Wang D; Guo W; Cheng X; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M
Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):885-9. PubMed ID: 11832187
[TBL] [Abstract][Full Text] [Related]
8. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
[TBL] [Abstract][Full Text] [Related]
9. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
10. [Alterations of FHIT gene and p16 gene in lung cancer and metastatic hilar lymph nodes].
Wang X; Sun Y; Li W
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):108-11. PubMed ID: 11776848
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
13. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
Marchetti A; Buttitta F; Pellegrini S; Bertacca G; Chella A; Carnicelli V; Tognoni V; Filardo A; Angeletti CA; Bevilacqua G
J Pathol; 1997 Feb; 181(2):178-82. PubMed ID: 9120722
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
15. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
16. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
[TBL] [Abstract][Full Text] [Related]
17. [Mutation analysis of p16 gene in non-small cell lung carcinomas].
Fu S; Wang B; Huang C; Liu Q; Zhang G; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):293-5. PubMed ID: 10514534
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray.
Ye Y; Wang D; Su C; Rong T; Guo A
Genet Mol Res; 2009 Dec; 8(4):1509-18. PubMed ID: 20082263
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of p16, p53 and p21 genes on the proliferation of lung cancer cells in vitro].
Wen G; Li J; Zou G; Fan X; Rao W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):169-72. PubMed ID: 11812373
[TBL] [Abstract][Full Text] [Related]
20. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
